Top Markets
#1 Black Phoenix Black Phoenix +21,471.53%
#2 Nesa Nesa +742.33%
#3 Kinesis Silver Kinesis Silver +54.95%
#4 Derive Derive +28.36%
#5 BNB Attestation Service BNB Attestation Service +24.81%
#6 QuantixAI QuantixAI +24.69%
#7 EXOD EXOD +22.78%
#8 Zylo Ecosystem Zylo Ecosystem +15.96%
#9 Pons Pons +15.89%
#10 Biconomy Biconomy +15.66%
Coin of the day
Black Phoenix Black Phoenix
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Inari Medical, Inc. Inari Medical, Inc.

Inari Medical, Inc.

NARI
Peringkat dalam Saham #3844
Inari Medical, Inc. is a medical technology firm focused on creating,... Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.
Harga Saham
$79.97
Terakhir disinkronkan: 2025-02-19
Kapitalisasi Pasar
$4.57B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Inari Medical, Inc. (NARI)

Kategori

Healthcare
Rasio P/E untuk Inari Medical, Inc. (NARI)
Rasio P/E per August 2026 TTM: -2.78K
Menurut laporan keuangan dan harga saham terbaru dari Inari Medical, Inc., rasio P/E saat ini (TTM) adalah -2.78K. Pada akhir 2022, perusahaan memiliki rasio P/E sebesar -114.75.
Riwayat rasio P/E untuk Inari Medical, Inc. dari 2018 hingga 2026
Rasio P/E di akhir setiap tahun
Tahun Rasio P/E Mengubah
2026 (TTM) -2.78K 23.26%
2023 -2.25K 1,863.22%
2022 -114.75 -124.83%
2021 462.06 127.86%
2020 202.79 -118.88%
2019 -1.07K 470.60%
2018 -188.21 0.00%
Rasio P/E untuk perusahaan serupa atau pesaing
Perusahaan Rasio P/E Perbedaan Rasio P/E Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 -101.29%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 -101.26%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -100.77%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -100.75%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE
Bagaimana cara membaca P/E ratio?

Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.

Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.

Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.